Date published: 2026-5-16

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olr526 Inhibitors

Olr526 inhibitors represent a specific chemical class that targets the activity of the Olr526 receptor, a protein encoded by the Olr526 gene. This receptor is a member of the olfactory receptor family, which is part of the larger G-protein-coupled receptor (GPCR) superfamily. Olr526 is involved in the detection of specific odorants, playing a role in olfactory signal transduction. Inhibitors of Olr526 are designed to interact with the receptor's binding site, either competitively or non-competitively, to prevent its normal function in signal transduction. These inhibitors may have distinct chemical structures but share a common mechanism of action focused on altering the receptor's conformation or its interaction with G-proteins, which are crucial for downstream signaling pathways.

The structural diversity of Olr526 inhibitors reflects the complexity of their interactions with the receptor. These molecules often feature hydrophobic and aromatic functional groups that align with the binding pocket of Olr526, optimizing their interaction with the receptor's ligand-binding domain. Additionally, some inhibitors might possess conformational flexibility, allowing them to adapt to the dynamic nature of the receptor's binding site. Understanding the binding kinetics and the specific molecular interactions between Olr526 inhibitors and their target receptor is key to unraveling the fundamental mechanisms underlying olfactory signal modulation. Research in this area not only expands knowledge of olfactory receptor biology but also provides valuable insights into the design of molecules that can precisely modulate GPCR activity, contributing to broader fields such as molecular biology and chemical signaling.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

BYL719

1217486-61-7sc-391001
sc-391001A
sc-391001B
sc-391001C
sc-391001D
sc-391001E
5 mg
10 mg
50 mg
100 mg
500 mg
1 g
$391.00
$597.00
$755.00
$1192.00
$5000.00
$9370.00
2
(0)

Inhibits PI3K, potentially altering proteins involved in the AKT/mTOR signaling pathway.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

Proteasome inhibitor, potentially affecting protein degradation and cell cycle regulation.

Capecitabine

154361-50-9sc-205618
sc-205618A
sc-205618B
250 mg
1 g
5 g
$64.00
$208.00
$322.00
16
(1)

Metabolized to 5-FU, potentially affecting proteins involved in DNA synthesis and repair.

Docetaxel

114977-28-5sc-201436
sc-201436A
sc-201436B
5 mg
25 mg
250 mg
$87.00
$332.00
$1093.00
16
(1)

Microtubule inhibitor, potentially affecting cell division and mitotic proteins.

Erlotinib, Free Base

183321-74-6sc-396113
sc-396113A
sc-396113B
sc-396113C
sc-396113D
500 mg
1 g
5 g
10 g
100 g
$87.00
$135.00
$293.00
$505.00
$3827.00
42
(0)

Inhibits EGFR tyrosine kinase, potentially affecting proteins in the EGFR signaling pathway.

Ibrutinib

936563-96-1sc-483194
10 mg
$156.00
5
(0)

Inhibits Bruton's tyrosine kinase, potentially affecting proteins in B-cell receptor signaling.

Lapatinib

231277-92-2sc-353658
100 mg
$420.00
32
(1)

Dual inhibitor of EGFR and HER2, potentially affecting proteins in associated signaling pathways.

Olaparib

763113-22-0sc-302017
sc-302017A
sc-302017B
250 mg
500 mg
1 g
$210.00
$305.00
$495.00
10
(1)

PARP inhibitor, potentially affecting proteins involved in DNA repair pathways.

Pazopanib

444731-52-6sc-396318
sc-396318A
25 mg
50 mg
$130.00
$182.00
2
(1)

Inhibits VEGF receptors, potentially affecting proteins involved in angiogenesis and tumor growth.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$57.00
$100.00
$250.00
129
(3)

Inhibits multiple kinases, potentially affecting proteins in cell signaling and growth pathways.